中文 | English
Return
Total: 292 , 1/30
Show Home Prev Next End page: GO
Author:(WU Shi-xing)

1.Exploring Biological Characteristics of Rat Model of Atrial Fibrillation with Phlegm-heat and Blood Stasis Pattern Based on Metabolomics

Ailin HOU ; Yuxuan LIU ; Wenxi YU ; Xing JI ; Chan WU ; Dazhuo SHI ; Ying ZHANG

Chinese Journal of Experimental Traditional Medical Formulae 2026;32(5):245-255

2.Kidney Gastrin/CCKBR Attenuates Type 2 Diabetes Mellitus by Inhibiting SGLT2-Mediated Glucose Reabsorption through Erk/NF-κB Signaling Pathway

Xue ZHANG ; Yuhan ZHANG ; Yang SHI ; Dou SHI ; Min NIU ; Xue LIU ; Xing LIU ; Zhiwei YANG ; Xianxian WU

Diabetes & Metabolism Journal 2025;49(2):194-209

3.Establishment of different pneumonia mouse models suitable for traditional Chinese medicine screening.

Xing-Nan YUE ; Jia-Yin HAN ; Chen PAN ; Yu-Shi ZHANG ; Su-Yan LIU ; Yong ZHAO ; Xiao-Meng ZHANG ; Jing-Wen WU ; Xuan TANG ; Ai-Hua LIANG

China Journal of Chinese Materia Medica 2025;50(15):4089-4099

4.Hippocampal Extracellular Matrix Protein Laminin β1 Regulates Neuropathic Pain and Pain-Related Cognitive Impairment.

Ying-Chun LI ; Pei-Yang LIU ; Hai-Tao LI ; Shuai WANG ; Yun-Xin SHI ; Zhen-Zhen LI ; Wen-Guang CHU ; Xia LI ; Wan-Neng LIU ; Xing-Xing ZHENG ; Fei WANG ; Wen-Juan HAN ; Jie ZHANG ; Sheng-Xi WU ; Rou-Gang XIE ; Ceng LUO

Neuroscience Bulletin 2025;41(12):2127-2147

5.Kidney Gastrin/CCKBR Attenuates Type 2 Diabetes Mellitus by Inhibiting SGLT2-Mediated Glucose Reabsorption through Erk/NF-κB Signaling Pathway

Xue ZHANG ; Yuhan ZHANG ; Yang SHI ; Dou SHI ; Min NIU ; Xue LIU ; Xing LIU ; Zhiwei YANG ; Xianxian WU

Diabetes & Metabolism Journal 2025;49(2):194-209

6.Kidney Gastrin/CCKBR Attenuates Type 2 Diabetes Mellitus by Inhibiting SGLT2-Mediated Glucose Reabsorption through Erk/NF-κB Signaling Pathway

Xue ZHANG ; Yuhan ZHANG ; Yang SHI ; Dou SHI ; Min NIU ; Xue LIU ; Xing LIU ; Zhiwei YANG ; Xianxian WU

Diabetes & Metabolism Journal 2025;49(2):194-209

7.Kidney Gastrin/CCKBR Attenuates Type 2 Diabetes Mellitus by Inhibiting SGLT2-Mediated Glucose Reabsorption through Erk/NF-κB Signaling Pathway

Xue ZHANG ; Yuhan ZHANG ; Yang SHI ; Dou SHI ; Min NIU ; Xue LIU ; Xing LIU ; Zhiwei YANG ; Xianxian WU

Diabetes & Metabolism Journal 2025;49(2):194-209

8.Development and application on a full process disease diagnosis and treatment assistance system based on generative artificial intelligence.

Wanjie YANG ; Hao FU ; Xiangfei MENG ; Changsong LI ; Ce YU ; Xinting ZHAO ; Weifeng LI ; Wei ZHAO ; Qi WU ; Zheng CHEN ; Chao CUI ; Song GAO ; Zhen WAN ; Jing HAN ; Weikang ZHAO ; Dong HAN ; Zhongzhuo JIANG ; Weirong XING ; Mou YANG ; Xuan MIAO ; Haibai SUN ; Zhiheng XING ; Junquan ZHANG ; Lixia SHI ; Li ZHANG

Chinese Critical Care Medicine 2025;37(5):477-483

9.Role of Gold Nanorods Functionalized by Nucleic Acid Nanostructures Carrying Doxorubicin in Synergistic Anti-Cancer Therapy.

Hao WU ; Huang Shui MA ; Xing Han WU ; Qiang SUN ; Lin FENG ; Rui Fang JIANG ; Yan Hong LI ; Quan SHI

Biomedical and Environmental Sciences 2025;38(4):403-415

10.Early results and indications of Stand-alone oblique lateral interbody fusion in lumbar lesions.

Zhong-You ZENG ; Xing ZHAO ; Wei YU ; Yong-Xing SONG ; Shun-Wu FAN ; Xiang-Qian FANG ; Fei PEI ; Shi-Yang FAN ; Guo-Hao SONG

China Journal of Orthopaedics and Traumatology 2025;38(5):454-464

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 292 , 1/30 Show Home Prev Next End page: GO